MTLS Materialise NV - American Depositary Shares
Materialise NV - American Depositary Shares 정보 위키백과 회사 개요
Materialise NV, headquartered in Leuven, Belgium, is a company in the 3D printing / additive manufacturing sector.
더 보기
Materialise NV, headquartered in Leuven, Belgium, is a company in the 3D printing / additive manufacturing sector.
History
1990s
Materialise was founded in June 1990 by Wilfried Vancraen and his wife Hilde Ingelaere as a Rapid Prototyping service bureau. It was the first company of its kind in the Benelux region of Europe, through the acquisition of a single Stereolithography machine (the SLA 1).
In 1992, Materialise began mapping human anatomy digitally in three dimensions, using sliced CT image data, which lead to the development of its medical image processing software: Mimics. Concurrently, the team was also developing its industrial software solution, Magics. Both of these software solutions were later commercialized to promote growth.
In 1995, Materialise became the first company to produce 3D printed parts in more than one colour, specifically at this time for anatomical models produced using the stereolithography process to delineate the complexities of the anatomy (such as nerves, blood vessels and tumours) and allow surgeons to more precisely plan for operations.
The company developed and produced the first customised 3D printed surgical guide for a dental operation in 1996. These personalised guides were utilised during surgery to show surgeons bone cutting and drilling locations to apply implants. This knowledge was used to develop Materialise SimPlant software, allowing the surgeon to virtually plan the surgery and minimize invasive exploratory surgery.
The company launched one of the first 3D printing online ordering systems in 1997, Materialise NextDay, which later became Materialise OnSite. This service allowed 3D printing service customers to send digital 3D data, which could be printed and shipped the next day.
Demand for prototypes grew, leading Materialise to develop its Mammoth Stereolithography systems, which are capable of printing single-piece models with dimensions of more than 2 meters in the Y axis.
2000s
In the year 2000, hearing aid specialist Phonak approached Materialise to develop the Rapid Shell Modeling (RSM) software. This allowed the design process for customized, patient-specific hearing aid shells to become automated. The resulting designs could then be 3D printed to produce the customised hearing aids. This was the first high volume, end-use application of 3D printing, and today, 99% of the world's hearing aids are now produced using 3D printing.
Materialise acquired US company Columbia Scientific Inc, (CSI) in 2001, the creators of Sim/Plant and ImageMaster, which became the US headquarters for Materialise's dental division in that region.
In 2003 Materialise launched one of the first 3D printed consumer brands — .MGX by Materialise — for 3D printing end-use products as well as prototypes. In parallel, the company also acquired Fused Deposition Modelling (FDM) systems for industrial applications.
The following year, in 2004, Materialise introduced its 3-matic software, allowing 3D printer users to edit files directly in the STL format. Previously, if design changes were required in the digital model, designers had to make them in the CAD suite of choice before re-converting the entire file to STL again.
In 2006 Materialise launched RapidFit, developed as a 3D printed solution for shipping large parts with customized jigs and fixtures to prevent deformation or breakage while in transit.
In 2006 Materialise developed the first Titanium 3D printed skull implants, following the acquisition of OBL, which specialized in the creation of custom cranio-maxillfacial (CMF) implants, producing customized implants with intricate porous structures, that behave like natural bone and mimic its mechanical and thermal properties.
In 2008 Materialise introduced the e-Stage software which was the first software to automatically generate support structures for different geometries in Stereolitography. In the same year, the company launched i.materialise for the consumer market, making it possible for anyone to print their ideas using professional-quality equipment. Materialise also developed its first Build Processor to support running different 3D printing processes more efficiently within a single location.
2010s
In 2012, Materialise introduced Streamics to provide traceable quality control to industrial 3D printer users producing end-use parts within regulated industries.
Materialise went public on June 25, 2014 to enable expansion of its services and software development. The same year the company acquired OrthoView, a market leader in orthopaedic digital pre-operative planning software founded by Adrian Dwyer, John Chambers, and Peter Quinn, and officially established a new office in China in December with a focus on 3D printing Software and R&D, namely Materialise Shanghai Co. Ltd.
In 2016, the company opened a new and dedicated metal production facility in Bremen, Germany. Materialise HQ, Leuven, also acquired and started testing the multi jet fusion (MJF) process from HP. Production of parts with MJF started in the following year, 2017.
With the expansion of the AM Metal market, Materialise acquired ACTech in Germany to extend the company's metal capabilities, with a specific emphasis on low-volume production of highly complex metal parts. The acquisition also enabled Materialise to develop and improve its software suite for metal 3D printing.
== References ==
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
MTLS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
MTLS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
MTLS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 3 33.3%
- 매수 5 55.6%
- 보유 1 11.1%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
3 명의 애널리스트 · 2026-08-19실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $0.03 | $0.01 | 0.02% |
| 2025년 12월 31일 | $0.11 | $0.06 | 0.05% |
| 2025년 9월 30일 | $0.04 | $0.01 | 0.03% |
| 2025년 6월 30일 | $0.00 | $0.02 | -0.02% |
| 2024년 12월 31일 | $0.05 | $0.05 | -0.00% |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 68개의 제출자 · $55.5M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 9 (-2 이전 분기 대비) | 9 (+2 이전 분기 대비) | 16 (+1 이전 분기 대비) | 21 (0 이전 분기 대비) | +902K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Wilfried Vancraen, Hilde Ingelaere, Idem ×5 제출 서류 | 2025년 10월 30일 | 57.60% | 수정본 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 3 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.